EDGAR Filing Documents for 0000950123-19-002699

Form DRS - Draft Registration Statement:

SEC Accession No. 0000950123-19-002699

Filing Date

2019-03-15

Accepted

2019-03-15 14:49:37

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	1712667
2		filename2.htm	EX-3.1	131805
3		filename3.htm	EX-3.2	108666
4		filename4.htm	EX-4.2	248070
5		filename5.htm	EX-10.11	85726
6		filename6.htm	EX-21.1	2110
7	GRAPHIC	g692555g22s53.jpg	GRAPHIC	91161
8	GRAPHIC	g692555g33a61.jpg	GRAPHIC	34226
9	GRAPHIC	g692555g39g35.jpg	GRAPHIC	74888
10	GRAPHIC	g692555g40t78.jpg	GRAPHIC	119642
11	GRAPHIC	g692555g51n59.jpg	GRAPHIC	105997
12	GRAPHIC	g692555g62p22.jpg	GRAPHIC	148134
13	GRAPHIC	g692555g66k92.jpg	GRAPHIC	91976
14	GRAPHIC	g692555g68y82.jpg	GRAPHIC	97208
15	GRAPHIC	g692555g73n23.jpg	GRAPHIC	64015
16	GRAPHIC	g692555g75k63.jpg	GRAPHIC	74333
17	GRAPHIC	g692555g77w99.jpg	GRAPHIC	119333
18	GRAPHIC	g692555g90r10.jpg	GRAPHIC	52154
19	GRAPHIC	g692555g96s03.jpg	GRAPHIC	69901
	Complete submission text file	0000950123-19-002699.txt		3866415

Mailing Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355

Business Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355 610-725-1500

Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)